Zinc status in infants and children with cholestatic liver diseases and its effect on growth

Item Infomation

Full metadata record

DC Field	Value	Language
dc.contributor.author	Abdelhamid, Nehal	vi
dc.contributor.other	Wahby, Aliaa	vi
dc.contributor.other	Kandil, Manal E.	vi
dc.date.accessioned	2021-04-23T03:08:06Z	-
dc.date.available	2021-04-23T03:08:06Z	-
dc.date.issued	2019	-
dc.identifier.issn	2522-8307	vi
dc.identifier.uri	http://tailieuso.tlu.edu.vn/handle/DHTL/10772	-
dc.description.abstract	The mean initial serum zinc (± SD) in cholestatic and healthy control group was 1251 ± 558 and 1461 ± 506 ug/l, respectively (P > 0.05). Meanwhile, serum IGF1 median (IQR; range) in patients and control was 54 (118;10:780) ng/ml and 250 (387;55:635) ng/ml, respectively (p < 0.001). No statistically significant difference was found between post-Kasai patients and other cholestatic diseases. Children supplemented with zinc had their serum zinc 2223 ± 1042 ug/l (P < 0.001) and IGF1 median (IQR; range) 346 (370;50:825) ng/ml (P < 0.001). In addition, among anthropometric variables, height (length) Z-score and percentile were significantly improved (P < 0.01).	vi
dc.description.uri	https://bnrc.springeropen.com/articles/10.1186/s42269-019-0166-y	vi
dc.language	en	vi
dc.relation.ispartofseries	Bulletin of the National Research Centre, Vol 43:121 (2019)	vi
dc.subject	Zinc	vi
dc.subject	Children	vi
dc.subject	Cholestasis	vi
dc.subject	Liver diseases	vi
dc.title	Zinc status in infants and children with cholestatic liver diseases and its effect on growth	vi
dc.type	BB	vi
Appears in Collections:	Tài liệu mở

Files in This Item:

There are no files associated with this item.

Bạn đọc là cán bộ, giáo viên, sinh viên của Trường Đại học Thuỷ Lợi cần đăng nhập để Xem trực tuyến/Tải về